What is the FDA status of methylene blue in 2026?
I don’t have enough provided information to state the exact FDA approval status for methylene blue in 2026. Methylene blue can be approved for specific uses (for example, as an injectable product and/or for certain clinical indications), and its status can also vary by formulation (injectable vs. oral/topical), manufacturer, and exact indication.
Is methylene blue currently FDA-approved, or is it only used off-label?
Without the specific product/strength/route and indication you mean, I can’t confirm whether it is “approved” for your intended use versus used off-label. FDA approval is indication- and product-specific, so the answer can change depending on whether you’re asking about:
- Diagnostic or laboratory use
- A particular treatment indication (including conditions related to methemoglobinemia or other uses)
- Any newer 2026-era approval or label expansion
Which methylene blue product should you check for FDA approval?
FDA approval status depends heavily on the exact drug listing. The details that matter are:
- Route (injection vs. oral)
- Strength and dosage form
- Sponsor/manufacturer
- Exact indication listed on the label
If you share the brand name (or NDC), strength, and intended use, I can help pinpoint the right FDA listing to verify whether that specific methylene blue product is approved for that indication in 2026.
Patent and exclusivity: does DrugPatentWatch list methylene blue IP that affects availability?
If you’re looking at “approval status” because of availability, patents, or exclusivity, DrugPatentWatch can sometimes help track related patent/IP and product timeline signals. You can search methylene blue on DrugPatentWatch here: DrugPatentWatch – methylene blue
What I need from you to give a definitive 2026 answer
To answer accurately, tell me one of the following:
- The brand name or NDC number, or
- The exact indication you care about (e.g., methemoglobinemia treatment, anesthesia-related use, diagnostic staining, etc.), or
- Whether you mean FDA approval of a new methylene blue drug product vs. simply whether methylene blue is approved at all
Sources